Literature DB >> 21804234

Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.

Ravi Sheshala1, Nurzalina Khan, Yusrida Darwis.   

Abstract

The aims of the present research were to mask the intensely bitter taste of sumatriptan succinate and to formulate orally disintegrating tablets (ODTs) of the taste masked drug. Taste masking was performed by coating sumatriptan succinate with Eudragit EPO using spray drying technique. The resultant microspheres were evaluated for thermal analysis, yield, particle size, entrapment efficiency and in vitro taste masking. The tablets were formulated by mixing the taste masked microspheres with different types and concentrations of superdisintegrants and compressed using direct compression method followed by sublimation technique. The prepared tablets were evaluated for weight variation, thickness, hardness, friability, drug content, water content, in vitro disintegration time and in vitro drug release. All the tablet formulations disintegrated in vitro within 37-410 s. The optimized formulation containing 5% Kollidon CL-SF released more than 90% of the drug within 15 min and the release was comparable to that of commercial product (Suminat®). In human volunteers, the optimized formulation was found to have a pleasant taste and mouth feel and disintegrated in the oral cavity within 41 s. The optimized formulation was found to be stable and bioequivalent with Suminat®.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21804234     DOI: 10.1248/cpb.59.920

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

Review 1.  pH- and ion-sensitive polymers for drug delivery.

Authors:  Takayuki Yoshida; Tsz Chung Lai; Glen S Kwon; Kazuhiro Sako
Journal:  Expert Opin Drug Deliv       Date:  2013-08-09       Impact factor: 6.648

2.  Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.

Authors:  Xuelian Hu; Yingbo Li; Engjuan Zhang; Xianzhu Wang; Mao Xing; Qian Wang; Jian Lei; Hua Huang
Journal:  AAPS PharmSciTech       Date:  2012-11-22       Impact factor: 3.246

3.  Formulation and evaluation of sublingual tablets containing Sumatriptan succinate.

Authors:  Shailesh T Prajapati; Parth B Patel; Chhagan N Patel
Journal:  Int J Pharm Investig       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.